Julien Puech
Overview
Explore the profile of Julien Puech including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
2386
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rahmoun M, Aussel A, Bouzidi S, Pedergnana V, Malassigne V, Puech J, et al.
Tumour Virus Res
. 2024 Oct;
18:200294.
PMID: 39481538
Recurrent respiratory papillomatosis (RRP) is a rare, proliferative disease caused by human papillomavirus 6 (HPV6) and HPV11. RRP can occasionally spread and undergo malignant transformation. We analysed samples across time...
2.
Mirghani H, Tendron A, Auperin A, Casiraghi O, Classe M, Badoual C, et al.
Cancer Epidemiol
. 2024 Jun;
91:102603.
PMID: 38901087
Background: France has the sixth highest incidence of oropharyngeal cancer (OPC) in Europe, but the epidemiological impact of high-risk HPV (HR-HPV) remains poorly documented. The objective of our study was...
3.
Bouzidi S, Puech J, Fulla M, Gonzalez-Compta X, Pere H, Alemany L, et al.
Microbiol Resour Announc
. 2024 Mar;
13(4):e0118423.
PMID: 38441980
We communicate here two complete (HPV11) genomes recovered from one transitional and from one squamous inverted sinonasal papilloma, a rare proliferative disease in humans. Both genomes belong to the HPV11_A2...
4.
Lafont E, Blez D, Bildan M, Veyer D, Pere H, Puech J, et al.
Clin Infect Dis
. 2023 Dec;
79(3):798-800.
PMID: 38159041
No abstract available.
5.
Bruel T, Vrignaud L, Porrot F, Staropoli I, Planas D, Guivel-Benhassine F, et al.
Med
. 2023 Oct;
4(10):664-667.
PMID: 37837962
Antibodies effective against the recent Omicron sublineages are missing. By taking advantage of a multi-centric prospective cohort of immunocompromised individuals treated for mild-to-moderate COVID-19, Bruel et al. show that administration...
6.
Kervarrec T, Imbeaud S, Veyer D, Pere H, Puech J, Pekar-Lukacs A, et al.
Am J Surg Pathol
. 2023 Jul;
47(10):1077-1084.
PMID: 37505796
Digital papillary adenocarcinoma (DPA) is a rare sweat gland neoplasm that has exceptionally been reported outside acral locations. Recently, human papillomavirus 42 was identified as the main oncogenic driver of...
7.
Tsimba Lemba P, Boumba L, Pere H, Nganga P, Veyer D, Puech J, et al.
Infect Dis Now
. 2023 Jul;
53(8):104762.
PMID: 37454761
Introduction: Cervical cancer related to high risk-human papillomavirus (HR-HPV) is the second female cancer in the Republic of Congo (Congo). We herein evaluated the molecular epidemiology of cervical HPV infection...
8.
Bruel T, Vrignaud L, Porrot F, Staropoli I, Planas D, Guivel-Benhassine F, et al.
medRxiv
. 2023 Jul;
PMID: 37398037
Background: Monoclonal antibodies (mAbs) targeting the spike of SARS-CoV-2 prevent severe COVID-19. Omicron subvariants BQ.1.1 and XBB.1.5 evade neutralization of therapeutic mAbs, leading to recommendations against their use. Yet, the...
9.
Planas D, Bruel T, Staropoli I, Guivel-Benhassine F, Porrot F, Maes P, et al.
Nat Commun
. 2023 Feb;
14(1):824.
PMID: 36788246
Convergent evolution of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 lineages has led to the emergence of several new subvariants, including BA.2.75.2, BA.4.6. and BQ.1.1. The subvariant BQ.1.1 became predominant in...
10.
Planas D, Bruel T, Staropoli I, Guivel-Benhassine F, Porrot F, Maes P, et al.
bioRxiv
. 2022 Nov;
PMID: 36415455
Convergent evolution of SARS-CoV-2 Omicron BA.2, BA.4 and BA.5 lineages has led to the emergence of several new subvariants, including BA.2.75.2, BA.4.6. and BQ.1.1. The subvariants BA.2.75.2 and BQ.1.1 are...